Clinical Pharmacology & TherapeuticsVolume 104, Issue 1 p. 31-32 Letter to the Editor CYP-Mediated Drug–Drug Interaction Is Not a Major Determinant of Attenuation of Antiplatelet Function of Clopidogrel by Vonoprazan Mitsuhiro Nishihara, Corresponding Author Mitsuhiro Nishihara mitsuhiro.nishihara@takeda.com Global Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, USACorrespondence: Mitsuhiro Nishihara (mitsuhiro.nishihara@takeda.com)Search for more papers by this authorRichard Czerniak, Richard Czerniak Quantitative Clinical Pharmacology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, USASearch for more papers by this author Mitsuhiro Nishihara, Corresponding Author Mitsuhiro Nishihara mitsuhiro.nishihara@takeda.com Global Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, USACorrespondence: Mitsuhiro Nishihara (mitsuhiro.nishihara@takeda.com)Search for more papers by this authorRichard Czerniak, Richard Czerniak Quantitative Clinical Pharmacology, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, USASearch for more papers by this author First published: 30 March 2018 https://doi.org/10.1002/cpt.1060Citations: 4Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume104, Issue1Digital DevicesJuly 2018Pages 31-32 RelatedInformation